Government of Canada also announces that Aramis Biotechnologies secured the assets needed to maintain, improve and expand Medicago’s plant-based technology platform in Canada that will enhance pandemic preparedness capabilities Québec – Following the cessation of Medicago’s operations by its parent company Mitsubishi Chemical Group Corporation (“MCG”) in February 2023, the Government of Canada’s objectives were threefold: maintain Medicago’s intellectual property …